Super High Contrast USPIO-Enhanced Cerebrovascular Angiography Using Ultrashort Time-to-Echo MRI
Background. Ferumoxytol (Ferahame, AMAG Pharmaceuticals, Waltham, MA) is increasingly used off-label as an MR contrast agent due to its relaxivity and safety profiles. However, its potent T2∗ relaxivity limits achievable T1-weighted positive contrast and leads to artifacts in standard MRI protocols....
Saved in:
Main Authors: | Liam Timms, Tianyi Zhou, Ju Qiao, Codi Gharagouzloo, Vishala Mishra, Rita Maria Lahoud, John W. Chen, Mukesh Harisinghani, Srinivas Sridhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | International Journal of Biomedical Imaging |
Online Access: | http://dx.doi.org/10.1155/2024/9763364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of diagnostic performance for pulmonary nodule detection between free-breathing spiral ultrashort echo time and free-breathing radial volumetric interpolated breath-hold examination
by: Yehai Jiang, et al.
Published: (2025-01-01) -
Impulse Force Balance for Ultrashort Duration Hypersonic Test Facilities
by: P. Singh, et al.
Published: (2015-01-01) -
Considerations for Use of Ultrashort Wave Therapy in Management of COVID-19 Patients
by: Pengming YU, et al.
Published: (2020-04-01) -
Carotid Artery Stenosis: Comparison of 3D Time-of-Flight MR Angiography and Contrast-Enhanced MR Angiography at 3T
by: Ivan Platzek, et al.
Published: (2014-01-01) -
Not an allergy: Iodine contrast-induced acute sialadenitis after coronary angiography
by: Victor Vallejo-Garcia, et al.
Published: (2025-01-01)